Mounjaro 12.5mg injection price: what private treatment costs in the UK

Step 1: understand how 12.5mg pricing sits within the tirzepatide dose ladder

Mounjaro comes in six strengths, and private pricing generally tracks upwards with dose. The 2.5mg starter pen costs less than the 10mg or 12.5mg pens, not because the service is different, but because Eli Lilly's supply price is higher for the upper doses. In September 2025, Eli Lilly raised the UK list price for Mounjaro substantially; the highest-dose pen moved from roughly £122 to roughly £330 at list price, as widely reported at the time. Private providers set their own fees on top of or within that range, so actual prices you'll see quoted vary. To understand how costs build as you move up the schedule, you can see what the 7.5mg injection is priced at and see what the 10mg injection is priced at before comparing them against the 12.5mg figure. For context on how the full pricing picture looks across the range, our overview of Mounjaro injection pricing sets this out in one place.

At 12.5mg you're one step below the 15mg ceiling. Some people stay here long-term if it's their highest tolerated dose; others move up. Either way, a prescriber (not you, and not a pricing page) makes that call, based on how your body has responded and whether you've reached clinical stability.

Step 2: work out what a quoted price actually includes

The number you see advertised is rarely the number you pay in total, unless you check. A few things to look for before committing: does the price include the prescriber's consultation, or is that billed separately? Is the prescription fee included, or charged on top? What about delivery, is it free, and is it tracked? And once you're on treatment, is ongoing clinical support available, or do you pay again each time you have a question?

A quick check that takes under a minute: search the GPhC register at pharmacyregulation.org/registers for any pharmacy you're considering. A GPhC-registered online pharmacy has to meet dispensing and clinical standards; one that doesn't appear on that register shouldn't be issuing prescription medicines at all. It's a small step and a useful filter.

At lower doses the gap between an all-in price and a stripped-back advertised price can look modest. At 12.5mg, where the supply cost is higher, the difference between what's promised and what's delivered matters more. The broader picture of what Mounjaro costs privately in the UK explains this in more detail.

Step 3: place the price against what's genuinely at stake

We're deliberately not the cheapest option for Mounjaro 12.5mg, and we'd rather say that plainly than dress it up. What one transparent price at nume covers: a free consultation, a free prescription reviewed by a named GPhC-registered Independent Prescriber (not a chatbot, not an algorithm), same-day dispatch when you order before 12pm once approved, free next-working-day DPD tracked delivery, and 7-day aftercare with clinical re-review before every repeat. No hidden fees. No subscription that continues without your say-so.

The MHRA has warned publicly about counterfeit tirzepatide pens entering the UK, fake pens seized from an illicit manufacturing site in 2025, alongside roughly 20 million doses of illegally traded weight-loss medicines worth around £45 million at street value. The sellers of those products quoted low prices. For a prescription medicine at this stage of your treatment, price is a reasonable consideration; it's just not the only one, and for most people it's not the right primary filter. Our full guide to Mounjaro covers the licensed supply chain and what to expect from a legitimate provider.

The clinical side: what 12.5mg means for where you are in treatment

By the time most people reach 12.5mg, they've been on tirzepatide for at least four or five months, titrating steadily from the 2.5mg tolerability dose. The SURMOUNT-1 trial (involving 2,539 adults over 72 weeks) found that participants on the highest doses achieved average weight reductions of around 20–21%, with 15mg producing the strongest results, as reported in the New England Journal of Medicine. Not everyone needs 15mg to reach their clinical goals, and some people do better staying at 12.5mg.

NICE's appraisal of tirzepatide (TA1026) recommends that continuing treatment is reviewed if less than 5% weight loss has occurred after six months at the highest tolerated dose. Your prescriber will look at that picture each time you request a repeat, which is why the clinical review before every order matters, not just at the start. If you're thinking about the full treatment journey rather than just the next pen, our weight-loss treatment overview explains how private treatment fits alongside lifestyle support.